![Gary Gordon](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Gary Gordon
Direktor/Vorstandsmitglied bei
TRISALUS LIFE SCIENCES, INC.
Vermögen: 329 921 $ am 30.06.2026
Profil
Dr. Gary B. Gordon is an Independent Director at TriSalus Life Sciences, Inc. and a Venture Advisor at Israel Biotech Fund.
He is on the Board of Directors at TriSalus Life Sciences, Inc., BioSight Ltd. and PhotonPharma, Inc. Dr. Gordon was previously employed as a Chief Medical Officer by Ayala Pharmaceuticals, Inc. /Old/, a Vice President-Oncology Development by AbbVie, Inc., a Divisional Vice President-Global Oncology by Abbott Laboratories, a Chief Scientific Officer & VP-Clinical Affairs by OVATION Pharmaceuticals, Inc., and an Assistant Professor by The Johns Hopkins University School of Medicine.
He also served on the board at G.D.
Searle Co. He received his undergraduate degree from Stony Brook University, an undergraduate degree from The State University of New York and a doctorate degree from The Johns Hopkins University School of Medicine.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 15.05.2026 | 72.510 ( 0,12 % ) | 329 921 $ | 30.06.2026 |
Aktive Positionen von Gary Gordon
| Unternehmen | Position | Beginn |
|---|---|---|
| TRISALUS LIFE SCIENCES, INC. | Direktor/Vorstandsmitglied | 29.01.2025 |
BioSight Ltd.
 BioSight Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biotech pharmaceutical company that provides cancer drug development services | Direktor/Vorstandsmitglied | 18.05.2020 |
PhotonPharma, Inc.
 PhotonPharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as an autologous therapy company for solid tumor cancers | Direktor/Vorstandsmitglied | - |
Israel Biotech Fund
 Israel Biotech Fund Investment ManagersFinance Israel Biotech invests in companies located in Israel. The firm targets companies operating in the fields of biotechnology and pharmaceutical sectors. It provides financing for early stage capital requirements. | Berater | - |
Ehemalige bekannte Positionen von Gary Gordon
| Unternehmen | Position | Ende |
|---|---|---|
| ADVAXIS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2023 |
| ABBVIE INC. | Corporate Officer/Principal | 01.04.2018 |
| ABBOTT LABORATORIES | Corporate Officer/Principal | 01.12.2012 |
OVATION Pharmaceuticals, Inc.
 OVATION Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets pharmaceuticals | Technik-/Wissenschafts-/F&E-Leiter | 01.04.2003 |
G.D. Searle Co.
 G.D. Searle Co. Miscellaneous Commercial ServicesCommercial Services Provides services and products related to life sciences | Private Equity Investor | - |
Ausbildung von Gary Gordon
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
72
Beziehungen ersten Grades
12
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 12 |
|---|---|
Abbott Laboratories
 Abbott Laboratories Medical SpecialtiesHealth Technology Develops and manufactures medical devices, diagnostic systems, pharmaceuticals & nutritional products | Health Technology |
AbbVie, Inc.
 AbbVie, Inc. Pharmaceuticals: MajorHealth Technology Engages in the research and development, manufacturing, commercialization & sale of immunology medicines and therapies | Health Technology |
Stony Brook University
 Stony Brook University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
OVATION Pharmaceuticals, Inc.
OVATION Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets pharmaceuticals | Health Technology |
The State University of New York
 The State University of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BioSight Ltd.
BioSight Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biotech pharmaceutical company that provides cancer drug development services | Health Technology |
The Johns Hopkins University School of Medicine
 The Johns Hopkins University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Israel Biotech Fund
Israel Biotech Fund Investment ManagersFinance Israel Biotech invests in companies located in Israel. The firm targets companies operating in the fields of biotechnology and pharmaceutical sectors. It provides financing for early stage capital requirements. | Finance |
Old Ayala, Inc.
 Old Ayala, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage oncology company which develops cancer therapies | Health Technology |
G.D. Searle Co.
G.D. Searle Co. Miscellaneous Commercial ServicesCommercial Services Provides services and products related to life sciences | Commercial Services |
PhotonPharma, Inc.
PhotonPharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as an autologous therapy company for solid tumor cancers | Health Technology |
TriSalus Life Sciences, Inc.
 TriSalus Life Sciences, Inc. Medical SpecialtiesHealth Technology Engages in research, development and sales of innovative drug delivery technology & immune-oncology therapeutics | Health Technology |
Wählen Sie MarketScreener 
